Literature DB >> 10077617

Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.

Y Pekarsky1, C Hallas, M Isobe, G Russo, C M Croce.   

Abstract

The TCL1 oncogene on human chromosome 14q32.1 is involved in the development of T cell leukemia in humans. Its expression in these leukemias is activated by chromosomal translocations and inversions at 14q32.1. Here we report the isolation and characterization of a new member of the TCL1 gene family, TCL1b, located approximately 16 kb centromeric of TCL1. The 1.2-kb TCL1b cDNA encodes a 14-kDa protein of 128 aa and shows 60% similarity to Tcl1. Expression profiles of TCL1 and TCL1b genes are very similar: both genes are expressed at very low levels in normal bone marrow and peripheral lymphocytes but are activated in T cell leukemia by rearrangements of the 14q32.1 region. Thus, translocations and inversions at 14q32. 1 in T cell malignancies involve two oncogenes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10077617      PMCID: PMC15875          DOI: 10.1073/pnas.96.6.2949

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Crystal structure of MTCP-1: implications for role of TCL-1 and MTCP-1 in T cell malignancies.

Authors:  Z Q Fu; G C Du Bois; S P Song; I Kulikovskaya; L Virgilio; J L Rothstein; C M Croce; I T Weber; R W Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

2.  Chromosome walking on the TCL1 locus involved in T-cell neoplasia.

Authors:  L Virgilio; M Isobe; M G Narducci; P Carotenuto; B Camerini; N Kurosawa; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

3.  Identification of the TCL1 gene involved in T-cell malignancies.

Authors:  L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

4.  TCL1 is overexpressed in patients affected by adult T-cell leukemias.

Authors:  M G Narducci; A Stoppacciaro; K Imada; T Uchiyama; L Virgilio; C Lazzeri; C M Croce; G Russo
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

5.  Deregulated expression of TCL1 causes T cell leukemia in mice.

Authors:  L Virgilio; C Lazzeri; R Bichi; K Nibu; M G Narducci; G Russo; J L Rothstein; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

6.  The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.

Authors:  Y Pekarsky; T Druck; M G Cotticelli; M Ohta; J Shou; J Mendrola; J C Montgomery; A M Buchberg; L D Siracusa; G Manenti; L Y Fong; T A Dragani; C M Croce; K Huebner
Journal:  Cancer Res       Date:  1998-08-01       Impact factor: 12.701

7.  Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia.

Authors:  C Gritti; H Dastot; J Soulier; A Janin; M T Daniel; A Madani; G Grimber; P Briand; F Sigaux; M H Stern
Journal:  Blood       Date:  1998-07-15       Impact factor: 22.113

8.  Characteristics of Epstein-Barr virus transformed B cell lines from patients with Alzheimer's disease and age-matched controls.

Authors:  A Ounanian; B Guilbert; J M Seigneurin
Journal:  Mech Ageing Dev       Date:  1992-03-15       Impact factor: 5.432

9.  Amplification of the TCL1 flanking region at 14q32.1 with no TCL1 gene transcription in a patient with peripheral T cell lymphoma.

Authors:  H Kobayashi; N Satake; N Maseki; M Sakurai; T Izumo; M Isobe; Y Kaneko
Journal:  Leukemia       Date:  1998-06       Impact factor: 11.528

10.  Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

Authors:  J Takizawa; R Suzuki; H Kuroda; A Utsunomiya; Y Kagami; T Joh; Y Aizawa; R Ueda; M Seto
Journal:  Jpn J Cancer Res       Date:  1998-07
View more
  28 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

Review 2.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

3.  Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies.

Authors:  Eugenio Gaudio; Riccardo Spizzo; Francesco Paduano; Zhenghua Luo; Alexey Efanov; Alexey Palamarchuk; Amanda S Leber; Mohamed Kaou; Nicola Zanesi; Arianna Bottoni; Stefan Costinean; Laura Z Rassenti; Tatsuya Nakamura; Thomas J Kipps; Rami I Aqeilan; Yuri Pekarsky; Francesco Trapasso; Carlo M Croce
Journal:  Blood       Date:  2011-11-07       Impact factor: 22.113

4.  Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.

Authors:  Ke Lan; Masanao Murakami; Tathagata Choudhuri; Donald E Tsai; Stephen J Schuster; Mariusz A Wasik; Erle S Robertson
Journal:  J Clin Virol       Date:  2008-09-14       Impact factor: 3.168

Review 5.  Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.

Authors:  Philipp B Staber; Marco Herling; Mar Bellido; Eric D Jacobsen; Matthew S Davids; Tapan Mahendra Kadia; Andrei Shustov; Olivier Tournilhac; Emmanuel Bachy; Francesco Zaja; Kimmo Porkka; Gregor Hoermann; Ingrid Simonitsch-Klupp; Claudia Haferlach; Stefan Kubicek; Marius E Mayerhoefer; Georg Hopfinger; Ulrich Jaeger; Claire Dearden
Journal:  Blood       Date:  2019-07-10       Impact factor: 22.113

6.  T-cell prolymphocytic leukemia.

Authors:  Robbie L Graham; Barry Cooper; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

7.  The TCL1 function revisited focusing on metabolic requirements of stemness.

Authors:  Maria Teresa Fiorenza; Alessandro Rava
Journal:  Cell Cycle       Date:  2019-09-29       Impact factor: 4.534

8.  Tcrδ translocations that delete the Bcl11b haploinsufficient tumor suppressor gene promote atm-deficient T cell acute lymphoblastic leukemia.

Authors:  Lori A Ehrlich; Katherine Yang-Iott; Craig H Bassing
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Accurate molecular classification of cancer using simple rules.

Authors:  Xiaosheng Wang; Osamu Gotoh
Journal:  BMC Med Genomics       Date:  2009-10-30       Impact factor: 3.063

Review 10.  [Value of targeted treatment for testicular cancer: from molecular approaches to clinical possibilities].

Authors:  A Martinschek; C G Ruf; C Sparwasser; H U Schmelz
Journal:  Urologe A       Date:  2008-10       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.